Wound dressings

Surgical Clinics of North America

Volumn 83, Issue 3, 2003, Pages 617-638

  Lionelli, Gerald T ^a   Lawrence, W Thomas ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ALGINIC ACID; ANTIINFECTIVE AGENT; BACITRACIN; BIOBRANE; CADEXOMER IODINE; CALCIUM ALGINATE; COMFEEL; DUODERM; HYPOCHLORITE SODIUM; IODINE DERIVATIVE; MACROGOL; MAFENIDE; MAFENIDE ACETATE; NEOMYCIN; NEOSPORIN; PETROLATUM; POLYMYXIN B; POLYSPORIN; POLYURETHAN; POVIDONE IODINE; PSEUDOMONIC ACID; SCARLET RED; SILVER NITRATE; SULFADIAZINE SILVER; VALNOCTAMIDE;

ANTIMICROBIAL THERAPY; DEBRIDEMENT; FILM; HUMAN; HYDROCOLLOID; HYDROGEL; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING; WOUND; WOUND DRESSING; WOUND HEALING;

EID: 0038174847     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(02)00192-5     Document Type: Review

References (77)

1. A brief history of wound healing. Yardley, PA: Oxford Clinical Communications; 1998.
2. Fish F, Dawson JO. Surgical dressings, ligatures, and sutures. London: William Heinemann Medical Books; 1967.
3. Pollack S. Wound healing: a review. II. environmental factors affecting wound healing. J Enterostom Ther 1982;9:14-6.
4. Snowden JM, Kennedy DF, Cliff WJ. Wound contraction: the effects of scab formation and the nature of the wound bed. Aust J Exp Biol Med Sci 1982;60:73-82.
5. Winter GD. Formation of the scab and the rate of epithelialization of superficial wounds of the skin in the young domestic pig. Nature 1962;193:293-4.
6. Bradley M, Cullum N, Nelson EA, et al. Systematic reviews of wound care management: (2) Dressings and topical agents used in the healing of chronic wounds. Health Technol Assess 1999;3(17 Pt 2):1-18.
7. Bolton L, Pirone L, Chen J, et al. Dressings' effects on wound healing. Wounds 1990;2:126-34.
8. Varghese MC, Balin AK, Carter M, et al. Local environment of chronic wounds under synthetic dressings. Arch Dermatol 1986;122:52-7.
9. Hunt TK, Zederfdeld B, Goldstick TK. Oxygen and healing. Am J Surg 1969;118:521-5.
10. Knighton DR, Silver IA, Hunt TK. Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery 1981;90:262-70.
11. Alvarez OM, Mertz PM, Eaglstein WH. The effect of occlusive dressings on collagen synthesis and reepithelialization in superficial wounds. J Surg Res 1983;35:142-8.
12. Alvarez O, Rozint J, Wiseman D. Moist environment: matching the dressing to the wound. Wounds 1989;1:35-51.
13. Barnett A, Berkowitz RL, Mills R, et al. Comparison of synthetic adhesive moisture vapor permeable and fine mesh gauze dressings for split-thickness skin graft donor sites. Am J Surg 1983;145:379-81.
14. Fodor PB. Scarlet red. Ann Plast Surg 1980;4:45-7.
15. Kaiser HJ, Kunze J. Topical antimicrobial therapy: the efficacy of clioquinol- and tribromphenolbismuth-zinc oxide preparations. Fortschr Med 1982;100:1265-7.
16. Williams C. Mepitel. Br J Nurs 1995;4:51-2, 54-5.
17. Troshev K, Kolev Z, Zlateva A, et al. Bacteriostatic and biologic stimulation effect of Mepitel on experimental burns on the skin of rats. Acta Chir Plast 1997;3:97-102.
18. Thomas S, Fear M, Humphreys J, et al. The effect of dressings on the production of exudate from venous leg ulcers. Wounds 1996;8:145-50.
19. Noe J. The mechanism of capillarity in surgical dressings. Surg Gynecol Obstet 1976;143:454-7.
20. Noe J. The problem of adherence in dressed wounds. Surg Gynecol Obstet 1978;147:185-8.
21. Wood RAB, Williams RHP, Hughes LE. Foam elastomer dressing in the management of open granulating wounds: experience with 250 patients. Br J Surg 1977;64:554-7.
22. Salisbury RE, Bevin AG, Dingeldein GP, et al. A clinical and laboratory evaluation of a polyurethane foam. Arch Surg 1979;114:1188-92.
23. Thomas S. Wound management and dressings. London: Pharmaceutical Press; 1990.
24. Piacquadio D, Nelson DB. Alginates: a 'new' dressing alternative. J Dermatol Surg Oncol 1992;18:990-8.
25. Thomas S, Loveless P. A comparative study of the properties of 12 hydrocolloid dressings. World Wide Wounds. Available at http://www.smtl.co.uk/World-WideWounds/1997/july/ThomasHydronet/ hydronet.html.
26. Angren MS. Four alginate dressings in the treatment of partial thickness wounds: a comparative experimental study. J Plast Surg 1996;49:129-34.
27. Miller TA. The deleterious effect of split skin homograft coverage on split-skin donor sites. Plast Reconstr Surg 1974;53:316-20.
28. Robson MC, Krizek TJ, Koss N, et al. Amniotic membranes as a temporary wound dressing. Surg Gynecol Obstet 1973;136:904-6.
29. Tavis MJ, Thornton JW. Bartlett: a new composite skin prosthesis. Burns 1979;7:123-30.
30. Zapata-Sirvent R, Hansbrough JF, Carroll W, et al. Comparison of Biobrane and Scarlet Red dressings for treatment of donor site wounds. Arch Surg 1985;120:743-5.
31. Noordenbos J, Dore C, Hansbrough JF. Safety and efficacy of TransCyte for the treatment of partial-thickness burns. J Burn Care Rehabil 1999;20:275-81.
32. Falanga V, Sabolinski M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen 1999;7:201-7.
33. Veves A, Falanga V, Armstrong DG, et al. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 2001;24:290-5.
34. Robson MC. Wound infection: a failure of wound healing caused by an imbalance of bacteria. Surg Clin N Am 1997;77:637-50.
35. Lineaweaver W, Howard R, Soucy D, et al. Topical antimicrobial toxicity. Arch Surg 1985;120:267-70.
36. Lineaweaver W, McMorris S, Soucy D, et al. Cellular and bacterial toxicities of topical antimicrobials. Plast Reconstr Surg 1985;75:394-6.
37. Dakins HD. The antiseptic action of hypochlorites: the ancient history of the "new antiseptic." BMJ 1915;2:809-10.
38. Kozol RA, Gillies C, Elgebaly SA. Effects of sodium hypochlorite (Dakin's Solution) on cells of the wound module. Arch Surg 1988;123:420-3.
39. Kjolseth D, Frank JM, Barker JH, et al. Comparison of the effects of commonly used wound agents on epithelialization and neovascularization. J Am Coll Surg 1994;179:305-12.
40. Stahl-Bayliss CM, Grandy RP, Fitzmartin RD, et al. The comparative efficacy and safety of 5% povidone-iodine for topical antisepsis. Ostomy Wound Manage 1990;31:40-9.
41. Cooper ML, Laer JA, Hansbrough JF. The cytotoxic effects of commonly used topical antimicrobial agents on human fibroblasts and keratinocytes. J Trauma 1991;31:775-84.
42. Kramer SA. Effect of povidone-iodine on wound healing: a review. J Vasc Nurs 1999;17:17-23.
43. Sundberg J, Meller R. A retrospective review of the use of cadexomer iodine in the treatment of chronic wounds. Wounds 1997;9:68-86.
44. Skog E. Epicutaneous testing with dextranomer iodine. In: Perstor Pharma Internal Report. Perstorp, Sweden: The Perstorp Group, Inc. 1984. p. 1-3.
45. Moyer CA, Brentano L, Gravens DL, et al. Treatment of large human burns with 0.5% silver nitrate solution. Arch Surg 1965;90:812-67.
46. Bellinger CG, Conway H. Effects of silver nitrate and sulfamylon on epithelial regeneration. Plast Reconstr Surg 1970;45:582-5.
47. Moncrief JA, Lindberg RB, Switzer WE, et al. Use of topical antibacterial therapy in the treatment of the burn wound. Arch Surg 1966;92:558-65.
48. Kucan JO, Smoot EC. Five percent mafenide acetate solution in the treatment of thermal injuries. J Burn Care Rehabil 1993;14:158-63.
49. Ballin JC. Evaluation of a new topical agent for burn therapy: Silver sulfadiazine (Silvadene). JAMA 1974;230:1184-5.
50. Fox CL. Topical therapy and the development of silver sulfadiazine. Surg. Gynecol Obstet 1983;157:82-8.
51. Klasen HJ. A historical review of the use of silver in the treatment of burns. II. renewed interest for silver. Burns 2000;26:131-8.
52. McCauley RL, Li YY, Poole B, et al. Differential inhibition of human basal keratinocyte growth to silver sulfadiazine and mafenide acetate. J Surg Res 1992;52:276-85.
53. Geronemus RG, Mertz PM, Eaglstein WH. Wound healing: the effects of topical antimicrobial agents. Arch Dermatol 1979;115:1311-4.
54. Tredget EE, Shankowsky HA, Groenveld A, et al. A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds. J Burn Care Rehabil 1998;19:531-7.
55. Eppelmann K, Doekel S, Marahiel MA. Engineered biosynthesis of the peptide antibiotic bacitracin in the surrogate host Bacillus subtilis. J Biol Chem 2001;276:34824-31.
56. Gilbert DN, Moellering RC, Sande MA, editors. The Sanford guide to antimicrobial therapy. 31st edition. Hyde Park, VT: Antimicrobial Therapy; 2001.
57. Hansbrough JF, Zapata-Sirvent RL, Cooper ML. Effects of topical antimicrobial agents on the human neutrophil respiratory burst. Arch Surg 1991;126:603-8.
58. Lacy C, Armstrong L, Ingrim N, Lance L, editors. Drug information handbook. 4th edition. Cleveland: American Pharmaceutical Association, Lexi-Comp Inc; 1996.
59. Dire DJ, Coppola M, Dwyer DA, et al. Prospective evaluation of topical antibiotics for preventing infections in uncomplicated soft-tissue wounds repaired in the ED. Acad Emerg Med 1995;2:4-10.
60. Leyden JJ. Mupirocin: a new topical antibiotic. J Am Acad Dermatol 1990;22:879-83.
61. Strock LL, Lee MM, Rutan RL, et al. Topical bactroban (mupirocin): efficacy in treating burn wounds infected with methicillin-resistant staphylococci. J Burn Care Rehabil 1990;11:454-9.
62. Bonn D. Maggot therapy: an alternative for wound infection. Lancet 2000;356:1174.
63. Thomas S, Jones M, Shutler S, et al. Using larvae in modern wound management. J Wound Care 1996;5:60-9.
64. Wollina U, Karte K, Herold C, et al. Biosurgery in wound healing: the renaissance of maggot therapy. J Eur Acad Dermatol Venereol 2000;14:285-9.
65. Dimarcq JL, Zachary D, Hoffmann JA, et al. Insect immunity: expression of the two major inducible antibacterial peptides, defensin and diptericin, in Phormia terranovae. EMBO J 1990;9:2507-15.
66. Freeman BG, Carwell GR, McCraw JB. The quantitative study of the use of dextranomer in the management of infected wounds. Surg Gynecol Obstet 1981;153:81-6.
67. Glasser ST. A new treatment for sloughing wounds: preliminary report. Am J Surg 1940;50:320-2.
68. Miller JM. The interaction of papain, urea and water-soluble chlorophyll in a proteolytic ointment for infected wounds. Surgery 1958;43:939-48.
69. Berger MM. Enzymatic debriding preparations. Ostomy Wound Manage 1993;39:61-9.
70. Rodeheaver G, Marsh D, Edgerton MT, et al. Proteolytic enzymes as adjuncts to antimicrobial prophylaxis of contaminated wounds. Am J Surg 1975;129:537-44.
71. Hobson D, White E, Anderson L, et al. Development and use of a quantitative method to evaluate the action of enzymatic wound debriding agents in vitro. Wounds 1998;10:105-10.
72. Alvarez OM, Fernandez-Obregon A, Rogers RS, et al. Chemical debridement of pressure ulcers: a prospective, randomized, comparative trial of collagenase and papain/urea formulations. Wounds 2000;12:15-25.
73. Morykwas MJ, Argenta LC, Shelton-Brown EI, et al. Vacuum-assisted closure: method for wound control and treatment: animal studies and basic foundation. Ann Plast Surg 1997;38:553-62.
74. Michie DD, Hugill JV. Influence of occlusive and impregnated gauze dressings on incisional healing: a prospective, randomized, controlled study. Ann Plast Surg 1994;32:57-64.
75. Gemberling RM, Miller TA, Caffee H, et al. Dressing comparison in the healing of donor sites. J Trauma 1976;16:812-4.
76. Prasad JK, Feller I, Thomson PD. A prospective controlled trial of Biobrane versus scarlet red on skin graft donor areas. J Burn Care Rehabil 1987;8:384-6.
77. Watcher MA, Wheeland RG. The role of topical agents in the healing of full-thickness wounds. J Dermatol Surg Oncol 1989;15:1188-95.